JAK inhibitors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
JAK inhibitors
Jun 26, 2024, 04:38 |
Insight
Andy Minn: Summary of our paper on combining JAK inhibitors with anti-PD1 for lung cancer
Andy Minn, Professor at University of Pennsylvania School of Medicine, shared a post on X: "Summary…
Jun 24, 2024, 12:01 |
Insight
Jean-Charles Soria: Two provocative manuscripts suggest the therapeutic potential of JAK inhibition with immunotherapy in cancer
Jean-Charles Soria shared a post on LinkedIn: "Two provocative manuscripts suggest the therapeutic potential of…
Jun 18, 2024, 02:37 |
Blog
Amer Zeidan: A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes
Amer Zeidan shared a post on X: “A wonderful talk by Dr. Emma M. Groarke on…
May 8, 2024, 01:20 |
Drugs
Talha Badar: Myelofibrosis after failure of Ruxolitinib
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube